The Vanderbilt-Ingram Cancer Center Department of Pharmacy Specialty Oncology Residency is a 12-month program. The graduate will obtain the specialized oncology knowledge base and clinical skills required to become competent in the pharmaceutical care of cancer patients. We are an accredited residency program by ASHP and follow their guidelines and vision closely. The resident will have opportunities in all aspects of oncology pharmacy practice related to clinical practice and outcomes, short-term research projects, and educating other health care professionals.
Blood & Marrow Transplantation
Investigational Drug Services
All rotations are four weeks in duration. One 4-week block will be designated as a transitional period dedicated to project time and meeting attendance and another 4-week block for orientation. The resident schedule is flexible in order to allow the resident to meet his/her career goals and interests.
|Benefits||Current Oncology Resident|
|TN Board of Pharmacy & NABP||Preceptors|
|Vanderbilt Community||Nashville, Tennessee|
Applicant must be a graduate of an accredited Doctor of Pharmacy program, be a licensed pharmacist in any state with reciprocation to Tennessee and completed an accredited PGY1 residency program.
Submit the following application materials for Oncology Residency to be received by January 1.
Number of Positions: One
Residency starting date: July 1
Mahsa S. Talbott, PharmD, BCOP, Program Director
|Estimated stipend - approx. $60,593*
1 position available
* info has not been verified